All News about Novartis Ag ADRVia Benzinga
Exposures
Product Safety
(NVS) - Analyzing Novartis's Short Interest
January 05, 2024
Via Benzinga
Novartis AG (NYSE: NVS) Records 52-Week High Friday Morning
January 05, 2024
Big Players' Recent Trades in NVS Options
January 04, 2024
Via Benzinga
Insufficient self-sufficiency of raw materials in Japan
January 08, 2024
Via AB Newswire
Topics
Supply Chain
Exposures
Supply Chain
Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery
January 08, 2024
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Via Talk Markets
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|